Autonomic and Peripheral Neurochemical Responses to Maximal Rowing Exercise
Integrated Autonomic, Neuroendocrine and Peripheral Neurochemical Responses to Maximal Rowing Exercise and Early Recovery in Elite Athletes
The goal of this observational study is to characterize autonomic, neuroendocrine, and peripheral neurochemical responses to maximal rowing exercise and early recovery in highly trained male athletes.
The main questions it aims to answer are:
- How do circulating concentrations of cortisol, testosterone, dopamine, serotonin, gamma-aminobutyric acid (GABA), and the testosterone-to-cortisol ratio change in response to maximal rowing exercise and during the first hour of recovery?
- How do autonomic cardiovascular parameters, including heart rate variability, blood pressure variability, and baroreflex sensitivity, change 3 hours after maximal exercise compared with baseline values?
- Do endocrine, peripheral neurochemical, and autonomic responses demonstrate similar or divergent recovery patterns following maximal exercise?
Participants will:
- Perform a maximal 6,000-m rowing ergometer test.
- Undergo venous blood sampling before exercise, immediately after exercise, and 1 hour after exercise recovery for assessment of endocrine and peripheral neurochemical markers.
- Undergo noninvasive cardiovascular and autonomic assessment using the Task Force Monitor System before exercise and 3 hours after exercise recovery.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This observational study was conducted to investigate physiological responses to maximal rowing exercise and subsequent recovery in highly trained male athletes. The study employed a repeated-measures design, allowing assessment of exercise-induced changes across multiple physiological systems during distinct phases of recovery.
Participants completed a maximal 6,000-m rowing ergometer test under standardized laboratory conditions. Biological and physiological measurements were collected before exercise and during recovery according to a predefined protocol. Venous blood samples were obtained at baseline, immediately after exercise, and after 1 hour of recovery. Noninvasive autonomic and cardiovascular assessments were performed using the Task Force Monitor System before exercise and after 3 hours of recovery. The protocol was designed to capture both immediate biochemical responses and delayed autonomic recovery following maximal exercise.
The study focused on endocrine, peripheral neurochemical, and autonomic cardiovascular regulation. Peripheral neurochemical markers were assessed from blood samples and interpreted as components of the peripheral physiological response to exercise rather than direct indicators of central nervous system activity.
Data collection was performed under controlled laboratory conditions using standardized procedures. All measurements were obtained by trained investigators using calibrated equipment. Data quality was verified through routine review of laboratory and physiological recordings. Implausible values and technical artifacts were identified and evaluated before statistical analysis.
The planned sample size was based on the availability of elite athletes meeting the inclusion criteria and the repeated-measures design of the study. Statistical analyses were conducted using repeated-measures approaches appropriate for longitudinal within-subject data. Data distribution was assessed prior to analysis. Parametric or non-parametric tests were applied as appropriate. Effect sizes were calculated to complement significance testing. Associations between selected physiological variables were explored using correlation analyses. Missing data were handled using complete-case analysis, with no imputation procedures applied.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Poznań
-
Poznan, Poznań, Polônia, 61-871
- Poznań University of Physical Education
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Highly trained rowers competing at the national or international level
- Regular participation in structured rowing training
- Current sports medical clearance for maximal exercise testing
- Ability to complete a maximal 6,000-m rowing ergometer test
- Written informed consent to participate in the study
Exclusion Criteria:
- Acute illness, infection, or injury before testing
- Diagnosed cardiovascular, metabolic, neurological, endocrine, or inflammatory disorder
- Use of medications or supplements that could affect cardiovascular, endocrine, metabolic, or neurochemical responses
- Inability to complete the maximal 6,000-m rowing ergometer test
- Inability or refusal to provide blood samples
- Non-compliance with study procedures or pre-test instructions
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Male elite rowers
|
Participants completed a single maximal 6,000-m rowing ergometer test.
The intervention was distinguished by a standardized all-out rowing protocol combined with peripheral blood sampling before exercise, immediately after exercise, and after 1 hour of recovery, as well as noninvasive autonomic and cardiovascular assessment at baseline and 3 hours after exercise.
|
|
Female elite rowers
|
Participants completed a single maximal 6,000-m rowing ergometer test.
The intervention was distinguished by a standardized all-out rowing protocol combined with peripheral blood sampling before exercise, immediately after exercise, and after 1 hour of recovery, as well as noninvasive autonomic and cardiovascular assessment at baseline and 3 hours after exercise.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline in serum cortisol concentration
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Marker of hypothalamic-pituitary-adrenal axis activation and exercise-induced endocrine response.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
|
Change from baseline in serum testosterone concentration
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Marker of anabolic status and exercise-induced endocrine response.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
|
Change from baseline in testosterone-to-cortisol ratio (T/C)
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Marker of anabolic-catabolic balance during exercise and recovery.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
|
Change from baseline in serum dopamine concentration
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Peripheral neurochemical marker associated with physiological responses to exercise and recovery.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
|
Change from baseline in serum serotonin concentration
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Peripheral neurochemical marker associated with exercise-induced physiological responses and recovery processes.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
|
Change from baseline in serum gamma-aminobutyric acid (GABA) concentration
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Peripheral neurochemical marker involved in physiological regulatory processes during exercise and recovery.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
|
Change from baseline in systolic blood pressure (sBP)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Continuous beat-to-beat systolic blood pressure measured using the Task Force Monitor System.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in diastolic blood pressure (dBP)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Continuous beat-to-beat diastolic blood pressure measured using the Task Force Monitor System.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in mean blood pressure (mBP)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Continuous beat-to-beat mean arterial pressure measured using the Task Force Monitor System.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in heart rate (HR)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Heart rate derived from continuous electrocardiographic recordings.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in total power spectral density of RR intervals (PSD-RRI)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Total spectral power of heart rate variability obtained from power spectral analysis of RR intervals.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in low-frequency power of RR intervals (LF-RRI)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Low-frequency component of heart rate variability (0.04-0.15 Hz), reflecting combined sympathetic and parasympathetic modulation.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in high-frequency power of RR intervals (HF-RRI)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
High-frequency component of heart rate variability (0.17-0.40 Hz), considered an indicator of parasympathetic modulation.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in LF/HF ratio
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Ratio of low-frequency to high-frequency spectral power used as an index of sympathovagal balance.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in baroreflex sensitivity (BRS)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Index of baroreflex function calculated using the spontaneous sequence method.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
|
Change from baseline in baroreflex effectiveness index (BEI)
Prazo: Baseline (pre-exercise) and 180 minutes post-exercise.
|
Index quantifying the effectiveness of baroreflex-mediated cardiovascular regulation.
|
Baseline (pre-exercise) and 180 minutes post-exercise.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change from baseline in blood lactate concentration
Prazo: Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Marker of metabolic response to maximal rowing exercise and early recovery.
|
Baseline (pre-exercise), 0 minutes post-exercise, and 60 minutes post-exercise.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Cadeira de estudo: Anna Skarpańska-Stejnborn, Professor, Poznan University of Physical Education, Gorzów Wielkopolski; Faculty of Sport Sciences in Gorzów Wielkopolski;
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- B-machine
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .